Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Saad

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
Emerging Infectious Diseases|September 16, 2006
Qinghai-like H5N1 from domestic cats, northern IraqSamuel L Yingst, Magdi D Saad, Stephen A Felt
Cancer Treatment Reviews|August 3, 2011
Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trialsKrzysztof Adamowicz, Jacek Jassem, Artur Katz, et al.
Biochemical and Biophysical Research Communications|February 12, 1981
Modulation of cortisol receptors in embryonic retina cells by changes in cell-cell contacts: correlations with induction of glutamine synthetaseA D Saad, B M Soh, A A Moscona
Proceedings (Baylor University. Medical Center)|November 10, 2005
Diagnostic molecular pathology: current techniques and clinical applications, part IGeorge J Netto, Rana D Saad, Peter A Dysert
Nature Reviews. Clinical Oncology|February 8, 2017
Precision medicine needs randomized clinical trialsEverardo D Saad, Xavier Paoletti, Tomasz Burzykowski, et al.
Cancer Treatment Reviews|March 27, 2012
Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trialsEverardo D Saad, Krzysztof Adamowicz, Artur Katz, et al.
Frontiers in Oncology|April 1, 2017
Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast CancerTomas Reinert, Everardo D Saad, Carlos H Barrios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?J Bines, H Earl, A C Buzaid, et al.
Cancer Investigation|February 21, 2002
Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experienceSamer Abushullaih, Everardo D Saad, Mark Munsell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literatureE D Saad, A Katz, P M Hoff, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
Emerging Infectious Diseases|September 16, 2006
Qinghai-like H5N1 from domestic cats, northern IraqSamuel L Yingst, Magdi D Saad, Stephen A Felt
Cancer Treatment Reviews|August 3, 2011
Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trialsKrzysztof Adamowicz, Jacek Jassem, Artur Katz, et al.
Biochemical and Biophysical Research Communications|February 12, 1981
Modulation of cortisol receptors in embryonic retina cells by changes in cell-cell contacts: correlations with induction of glutamine synthetaseA D Saad, B M Soh, A A Moscona
Proceedings (Baylor University. Medical Center)|November 10, 2005
Diagnostic molecular pathology: current techniques and clinical applications, part IGeorge J Netto, Rana D Saad, Peter A Dysert
Nature Reviews. Clinical Oncology|February 8, 2017
Precision medicine needs randomized clinical trialsEverardo D Saad, Xavier Paoletti, Tomasz Burzykowski, et al.
Cancer Treatment Reviews|March 27, 2012
Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trialsEverardo D Saad, Krzysztof Adamowicz, Artur Katz, et al.
Frontiers in Oncology|April 1, 2017
Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast CancerTomas Reinert, Everardo D Saad, Carlos H Barrios, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?J Bines, H Earl, A C Buzaid, et al.
Cancer Investigation|February 21, 2002
Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experienceSamer Abushullaih, Everardo D Saad, Mark Munsell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Progression-free survival as surrogate and as true end point: insights from the breast and colorectal cancer literatureE D Saad, A Katz, P M Hoff, et al.
Pageof 17